Elevidys is the initial accepted genetics treatment to deal with individuals with Duchenne muscle dystrophy.
发布者：BY ANNE GRETE STORVIK，转转请注明出处：https://robotalks.cn/roche-reports-positive-results-in-late-stage-study-of-genetic-muscle-disease/
Roche reports positive results in late-stage study of genetic muscle disease
赞 (0)
关于作者
Leo Pharma changes CEO in the US
上一篇
30 1 月, 2025 3:18 下午
Compounder warned by FDA after multiple breaches
下一篇
30 1 月, 2025 3:18 下午
相关推荐
-
Yamaha readies ebike battery swap service for pilot rollout
A number of years back, Yamaha released a brand-new sub-brand targeted at supplying ebike cyclists a battery swap alternative. Currently ENYRING has actually partnered with Swobbee…
-
Digital Twin Consortium Expands Scope by Encompassing Digital Engineering Methodologies
The Digital Double Consortium revealed a growth of its extent to consist of the growth and implementation of innovative electronic design approaches throughout the electronic doubl…
-
MOL invests in Singapore cold-chain specialist, CKL
The article MOL invests in Singapore cold-chain specialist, CKL showed up initially on Logistics Manager.
-
Redefining the warehouse floor
In an industry where speed, precision, and cost-efficiency rule, warehouse operations – particularly the picking process – remain a surprising pain point, writes Simon Allen, MD, B…
-
7 Bell Labs Breakthroughs Honored as IEEE Milestones
Bell Labs is already highly recognized, but in its centennial year, the organization hoped to add more awards to burnish its reputation as one of the world’s leading centers of tec…
